Lumos Director Doug Ward Increases On‑Market Shareholding
Lumos Diagnostics Updates Market on Director Doug Ward’s Increased Shareholding
Bell Potter Reaffirms Their Buy Rating on Lumos Diagnostics Holdings Ltd. (LDX)
Bell Potter Keeps Their Buy Rating on Lumos Diagnostics Holdings Ltd. (LDX)
Lumos Diagnostics Seeks ASX Quotation for 15.2 Million New Shares
Lumos Director Catherine Robson Increases Indirect Shareholding via Purchases and Share Plan